SCHEMBL5836657

SCHEMBL5836657

CC(CCO)CCO.O=C(O)Cl.O=C(O)Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
ALOX15 P16050 1/20 0.44
TRPA1 O75762 1/20 0.39
GABRP O00591 2/20 0.39
GABRD O14764 2/20 0.39
GABRA1 P14867 2/20 0.39
GABRB1 P18505 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39
GABRB2 P47870 2/20 0.39
GABRA4 P48169 2/20 0.39
GABRE P78334 2/20 0.39
GABRA6 Q16445 2/20 0.39
GABRG1 Q8N1C3 2/20 0.39
GABRG3 Q99928 2/20 0.39
GABRQ Q9UN88 2/20 0.39
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL18224038 0.88 ALDH1A1 (0.48) ALDH1A1ALOX15TRPA1GABRPGABRD
Acetic Acid SCHEMBL7950964 0.86 ALDH1A1 (0.52) ALDH1A1ALOX15TRPA1GABRPGABRD
SCHEMBL28762 0.82
Malonic Acid SCHEMBL30288558 0.81 LDHA (0.47) ALDH1A1ALOX15TRPA1GABRPGABRD
Propionic Acid SCHEMBL29086888 0.81 FFAR3 (0.53) ALDH1A1ALOX15TRPA1GABRPGABRD
Succinic Acid SCHEMBL28289303 0.81 GABRP (0.54) ALDH1A1ALOX15TRPA1GABRPGABRD
Pivalate SCHEMBL28604198 0.79 ALDH1A1 (0.41) ALDH1A1ALOX15TRPA1GABRPGABRD
SCHEMBL9299102 0.79 ALDH1A1 (0.41) ALDH1A1ALOX15TRPA1GABRPGABRD
Maleic Acid SCHEMBL28379908 0.79 ALDH1A1 (0.46) ALDH1A1ALOX15TRPA1GABRPGABRD
Pivalate SCHEMBL12076234 0.79 ALDH1A1 (0.41) ALDH1A1ALOX15TRPA1GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4635941-A1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE Nouryon Chemicals International B.V. (NL) 2025-10-22 EP claimed
EP-4471010-B1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE NOURYON CHEMICALS INT BV (NL) 2025-06-04 EP claimed
US-20240400490-A1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2024-12-05 US claimed
EP-4471010-A1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE Nouryon Chemicals International B.V. (NL) 2024-12-04 EP claimed
EP-4635941-A1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE Nouryon Chemicals International B.V. (NL) 2025-10-22 EP disclosed
EP-4471010-B1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE NOURYON CHEMICALS INT BV (NL) 2025-06-04 EP disclosed
US-20240400490-A1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE NOURYON CHEMICALS INTERNATIONAL B.V. (NL) 2024-12-05 US disclosed
EP-4471010-A1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE Nouryon Chemicals International B.V. (NL) 2024-12-04 EP disclosed
US-7078553-B2 Dehydrohalogenation by reacting a di-hydroperoxy compound with an acid halogen or halogen formate to form mono- or di-peroxy ester or carbonate; polymerization initiators, curing agents for unsaturated polyesters and modifying agents AKZO NOBEL N.V. (NL) 2006-07-18 US disclosed
US-20040260111-A1 Dehydrohalogenation by reacting a di-hydroperoxy compound with an acid halogen or halogen formate to form mono- or di-peroxy ester or carbonate; polymerization initiators, curing agents for unsaturated polyesters and modifying agents VAN DE BOVENKAMP-BOUWMAN ANNA (NL) 2004-12-23 US disclosed
EP-1071662-B1 PEROXIDES, THEIR PREPARATION PROCESS AND USE AKZO NOBEL NV (NL) 2004-08-04 EP disclosed
US-6770774-B2 USING A PEROXY COMPOUND AS CURING AGENT, POLYMERIZATION CATALYST AKZO NOBEL N.V. (NL) 2004-08-03 US disclosed
US-6552215-B1 Reacting a hydroperoxy compound containing a peroxyester or peroxycarbonate functionality with an alkyl vinyl ether; polymerization initiators, curing agents for unsaturated polyesters and modifying agents AKZO NOBEL N.V. (NL) 2003-04-22 US disclosed
US-20030073861-A1 Using a peroxy compound as curing agent, polymerization catalyst VAN DE BOVENKAMP-BOUWMAN ANNA (NL) 2003-04-17 US disclosed
EP-1049668-B1 KETONE PEROXIDE DERIVATIVES, THEIR PREPARATION AND USE AKZO NOBEL NV (NL) 2003-03-19 EP disclosed
US-6482970-B1 Peroxides, their preparation process and use AKZO NOBEL NV (NL) 2002-11-19 US disclosed
EP-1071662-A1 PEROXIDES, THEIR PREPARATION PROCESS AND USE Akzo Nobel N.V. (NL) 2001-01-31 EP disclosed
EP-1049668-A1 KETONE PEROXIDE DERIVATIVES, THEIR PREPARATION AND USE Akzo Nobel N.V. (NL) 2000-11-08 EP disclosed
WO-1999052864-A1 PEROXIDES, THEIR PREPARATION PROCESS AND USE AKZO NOBEL N.V. (NL) 1999-10-21 WO disclosed
WO-1999032442-A1 KETONE PEROXIDE DERIVATIVES, THEIR PREPARATION AND USE AKZO NOBEL N.V. (NL) 1999-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040260111-A1 Dehydrohalogenation by reacting a di-hydroperoxy compound with an acid halogen or halogen formate to form mono- or di-peroxy ester or carbonate; polymerization initiators, curing agents for unsaturated polyesters and modifying agents GPX4, HDHD5, HAO2 ALDH1A1 427/4885ALOX15 22/4885TRPA1 2508/4885
US-20240400490-A1 PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE GPX4, PRDX4, PRDX2 ALDH1A1 327/4885ALOX15 468/4885TRPA1 3272/4885
US-20030073861-A1 Using a peroxy compound as curing agent, polymerization catalyst PRDX4, ACOX3, PRDX2 ALDH1A1 846/4885ALOX15 164/4885TRPA1 1910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.